Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nuclear Medicine | 4 | 2021 | 233 | 2.400 |
Why?
|
Cardiology | 8 | 2022 | 1668 | 2.180 |
Why?
|
Heart Failure | 57 | 2023 | 10900 | 1.960 |
Why?
|
Ventricular Dysfunction, Left | 30 | 2023 | 2073 | 1.600 |
Why?
|
Laboratories | 4 | 2022 | 463 | 1.330 |
Why?
|
Ventricular Function, Left | 27 | 2023 | 3670 | 1.100 |
Why?
|
Sarcoidosis | 7 | 2019 | 506 | 1.080 |
Why?
|
Myocardial Perfusion Imaging | 8 | 2023 | 554 | 1.080 |
Why?
|
Hypertrophy, Left Ventricular | 7 | 2017 | 859 | 1.000 |
Why?
|
Stroke Volume | 31 | 2023 | 5007 | 0.890 |
Why?
|
Coronavirus Infections | 4 | 2020 | 3133 | 0.840 |
Why?
|
Pandemics | 7 | 2022 | 8388 | 0.830 |
Why?
|
Pneumonia, Viral | 4 | 2020 | 3240 | 0.830 |
Why?
|
Atherosclerosis | 10 | 2023 | 3445 | 0.770 |
Why?
|
Cardiovascular Diseases | 20 | 2024 | 15165 | 0.740 |
Why?
|
Exercise Test | 13 | 2023 | 2074 | 0.740 |
Why?
|
Cardiomyopathies | 8 | 2020 | 1912 | 0.730 |
Why?
|
Prediabetic State | 2 | 2015 | 499 | 0.710 |
Why?
|
Cardiac Resynchronization Therapy | 2 | 2016 | 531 | 0.680 |
Why?
|
Myocardial Infarction | 30 | 2023 | 11727 | 0.680 |
Why?
|
Laboratories, Hospital | 1 | 2020 | 194 | 0.670 |
Why?
|
Diabetes Mellitus | 8 | 2022 | 5751 | 0.670 |
Why?
|
Renal Insufficiency, Chronic | 7 | 2023 | 2208 | 0.620 |
Why?
|
Coronary Artery Disease | 12 | 2023 | 6487 | 0.610 |
Why?
|
Erythropoietin | 2 | 2012 | 726 | 0.610 |
Why?
|
Natriuretic Peptide, Brain | 8 | 2023 | 1573 | 0.580 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 9 | 2015 | 451 | 0.550 |
Why?
|
Ventricular Remodeling | 11 | 2023 | 1224 | 0.550 |
Why?
|
Practice Guidelines as Topic | 4 | 2021 | 7279 | 0.540 |
Why?
|
Hematinics | 3 | 2015 | 281 | 0.540 |
Why?
|
Tetrazoles | 14 | 2022 | 835 | 0.530 |
Why?
|
Troponin T | 5 | 2021 | 754 | 0.510 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 11 | 2023 | 1518 | 0.500 |
Why?
|
Anemia | 3 | 2015 | 1506 | 0.490 |
Why?
|
Electric Countershock | 1 | 2016 | 534 | 0.450 |
Why?
|
Amlodipine | 1 | 2013 | 83 | 0.450 |
Why?
|
Echocardiography | 16 | 2023 | 5102 | 0.450 |
Why?
|
Heart Ventricles | 12 | 2020 | 3821 | 0.440 |
Why?
|
Kidney Failure, Chronic | 6 | 2020 | 2538 | 0.420 |
Why?
|
Societies, Medical | 2 | 2021 | 3743 | 0.410 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 7 | 2023 | 1107 | 0.410 |
Why?
|
Positron-Emission Tomography | 12 | 2021 | 6234 | 0.400 |
Why?
|
Blood Glucose | 3 | 2018 | 6256 | 0.390 |
Why?
|
Fluorodeoxyglucose F18 | 7 | 2019 | 2016 | 0.390 |
Why?
|
Captopril | 6 | 2015 | 272 | 0.390 |
Why?
|
Prognosis | 40 | 2023 | 29063 | 0.380 |
Why?
|
Aged | 81 | 2024 | 163280 | 0.380 |
Why?
|
Calcium Channel Blockers | 1 | 2013 | 690 | 0.360 |
Why?
|
Glomerular Filtration Rate | 4 | 2017 | 2170 | 0.350 |
Why?
|
Humans | 136 | 2024 | 744343 | 0.340 |
Why?
|
Valine | 7 | 2008 | 413 | 0.340 |
Why?
|
Heart | 7 | 2023 | 4467 | 0.330 |
Why?
|
Angiotensin Receptor Antagonists | 3 | 2023 | 924 | 0.320 |
Why?
|
Male | 99 | 2024 | 350118 | 0.310 |
Why?
|
Spironolactone | 2 | 2023 | 382 | 0.310 |
Why?
|
Risk Factors | 38 | 2024 | 72290 | 0.310 |
Why?
|
Heart Rate | 5 | 2018 | 4091 | 0.300 |
Why?
|
Diabetes Complications | 6 | 2016 | 1359 | 0.290 |
Why?
|
Female | 100 | 2024 | 380194 | 0.290 |
Why?
|
Proportional Hazards Models | 23 | 2021 | 12354 | 0.290 |
Why?
|
Echocardiography, Doppler | 7 | 2019 | 935 | 0.290 |
Why?
|
Arrhythmias, Cardiac | 1 | 2016 | 2268 | 0.280 |
Why?
|
Hemoglobins | 1 | 2012 | 1534 | 0.280 |
Why?
|
Benzimidazoles | 6 | 2014 | 850 | 0.280 |
Why?
|
Outpatients | 1 | 2014 | 1486 | 0.270 |
Why?
|
Cardiac Output, Low | 1 | 2006 | 195 | 0.270 |
Why?
|
Fractional Flow Reserve, Myocardial | 2 | 2021 | 290 | 0.270 |
Why?
|
Exercise Tolerance | 4 | 2020 | 770 | 0.260 |
Why?
|
Diabetes Mellitus, Type 2 | 5 | 2023 | 11725 | 0.260 |
Why?
|
Middle Aged | 74 | 2024 | 213383 | 0.260 |
Why?
|
Risk Assessment | 18 | 2021 | 23338 | 0.260 |
Why?
|
Coronary Disease | 5 | 2019 | 6077 | 0.250 |
Why?
|
Stroke | 8 | 2023 | 9981 | 0.250 |
Why?
|
Radiopharmaceuticals | 9 | 2020 | 2645 | 0.240 |
Why?
|
Ventricular Dysfunction, Right | 3 | 2023 | 581 | 0.240 |
Why?
|
Aged, 80 and over | 28 | 2024 | 57776 | 0.240 |
Why?
|
Technetium Tc 99m Pyrophosphate | 2 | 2020 | 44 | 0.240 |
Why?
|
Pyrans | 1 | 2023 | 54 | 0.230 |
Why?
|
Peptide Fragments | 5 | 2022 | 5097 | 0.230 |
Why?
|
Cardiovascular System | 2 | 2023 | 832 | 0.230 |
Why?
|
Systole | 6 | 2019 | 958 | 0.220 |
Why?
|
Aortic Valve | 2 | 2024 | 1922 | 0.220 |
Why?
|
Predictive Value of Tests | 14 | 2023 | 15076 | 0.210 |
Why?
|
Inpatients | 1 | 2014 | 2518 | 0.210 |
Why?
|
Leisure Activities | 1 | 2024 | 311 | 0.210 |
Why?
|
Coronary Circulation | 4 | 2021 | 1572 | 0.210 |
Why?
|
Kaplan-Meier Estimate | 7 | 2016 | 6538 | 0.210 |
Why?
|
Hypertension | 7 | 2020 | 8480 | 0.200 |
Why?
|
Hospitalization | 10 | 2022 | 10262 | 0.190 |
Why?
|
Isosorbide Dinitrate | 1 | 2020 | 34 | 0.190 |
Why?
|
Tellurium | 1 | 2020 | 23 | 0.190 |
Why?
|
Multivariate Analysis | 8 | 2016 | 12245 | 0.190 |
Why?
|
Myocardial Contraction | 2 | 2018 | 1585 | 0.190 |
Why?
|
Fumarates | 2 | 2011 | 132 | 0.190 |
Why?
|
Troponin | 2 | 2019 | 524 | 0.180 |
Why?
|
Prospective Studies | 21 | 2024 | 53288 | 0.180 |
Why?
|
Heart Atria | 3 | 2022 | 1357 | 0.180 |
Why?
|
Tomography, X-Ray Computed | 11 | 2021 | 20129 | 0.180 |
Why?
|
United States | 21 | 2023 | 69872 | 0.180 |
Why?
|
Acute Kidney Injury | 2 | 2023 | 1972 | 0.170 |
Why?
|
Purines | 2 | 2013 | 594 | 0.170 |
Why?
|
Hypercholesterolemia | 2 | 2018 | 1151 | 0.170 |
Why?
|
Cadmium | 1 | 2020 | 212 | 0.170 |
Why?
|
Rubidium Radioisotopes | 3 | 2013 | 85 | 0.170 |
Why?
|
Renin | 2 | 2011 | 642 | 0.170 |
Why?
|
Feeding Behavior | 1 | 2011 | 3188 | 0.170 |
Why?
|
Radiation Dosage | 2 | 2019 | 1928 | 0.160 |
Why?
|
Ventricular Function, Right | 5 | 2023 | 591 | 0.160 |
Why?
|
Dyspnea | 3 | 2023 | 1303 | 0.160 |
Why?
|
Treatment Outcome | 21 | 2022 | 63114 | 0.160 |
Why?
|
Italy | 1 | 2020 | 832 | 0.160 |
Why?
|
Amides | 2 | 2011 | 459 | 0.160 |
Why?
|
Diastole | 5 | 2023 | 791 | 0.160 |
Why?
|
Coronary Angiography | 5 | 2021 | 4577 | 0.160 |
Why?
|
Follow-Up Studies | 20 | 2019 | 39050 | 0.160 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2023 | 1240 | 0.150 |
Why?
|
Cause of Death | 7 | 2017 | 3584 | 0.150 |
Why?
|
Diagnostic Imaging | 3 | 2020 | 3507 | 0.150 |
Why?
|
Randomized Controlled Trials as Topic | 8 | 2023 | 9959 | 0.150 |
Why?
|
Antihypertensive Agents | 3 | 2006 | 2046 | 0.150 |
Why?
|
Hyperkalemia | 1 | 2018 | 218 | 0.140 |
Why?
|
Obesity | 4 | 2022 | 12745 | 0.140 |
Why?
|
Blood Pressure | 7 | 2020 | 8554 | 0.140 |
Why?
|
Zinc | 1 | 2020 | 684 | 0.140 |
Why?
|
Safety | 1 | 2021 | 1186 | 0.140 |
Why?
|
Defibrillators, Implantable | 2 | 2016 | 1440 | 0.130 |
Why?
|
Health Status Disparities | 2 | 2018 | 1797 | 0.130 |
Why?
|
Biphenyl Compounds | 7 | 2022 | 913 | 0.130 |
Why?
|
Smoking | 4 | 2018 | 8987 | 0.130 |
Why?
|
Double-Blind Method | 8 | 2018 | 12026 | 0.130 |
Why?
|
Pulmonary Artery | 1 | 2023 | 1912 | 0.130 |
Why?
|
Calcinosis | 1 | 2024 | 1499 | 0.130 |
Why?
|
Albuminuria | 2 | 2017 | 682 | 0.130 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 738 | 0.130 |
Why?
|
Heart Valve Diseases | 1 | 2022 | 1073 | 0.120 |
Why?
|
Time Factors | 14 | 2018 | 40075 | 0.120 |
Why?
|
Severity of Illness Index | 6 | 2019 | 15540 | 0.120 |
Why?
|
Survival Rate | 10 | 2022 | 12788 | 0.120 |
Why?
|
Disease Progression | 7 | 2017 | 13284 | 0.120 |
Why?
|
Ankle Brachial Index | 1 | 2014 | 154 | 0.120 |
Why?
|
Tissue Survival | 1 | 2014 | 118 | 0.120 |
Why?
|
Survival Analysis | 9 | 2018 | 10252 | 0.120 |
Why?
|
Sex Factors | 7 | 2022 | 10397 | 0.120 |
Why?
|
Cardiac Imaging Techniques | 1 | 2016 | 269 | 0.120 |
Why?
|
Amyloidosis | 1 | 2020 | 795 | 0.120 |
Why?
|
Communicable Disease Control | 1 | 2020 | 857 | 0.120 |
Why?
|
Rest | 1 | 2018 | 901 | 0.110 |
Why?
|
Guidelines as Topic | 1 | 2020 | 1405 | 0.110 |
Why?
|
Cohort Studies | 16 | 2022 | 40561 | 0.110 |
Why?
|
Mitral Valve | 1 | 2022 | 1491 | 0.110 |
Why?
|
Creatinine | 2 | 2017 | 1919 | 0.110 |
Why?
|
Diet, Carbohydrate-Restricted | 1 | 2016 | 262 | 0.110 |
Why?
|
Age Factors | 6 | 2018 | 18370 | 0.110 |
Why?
|
Incidence | 10 | 2022 | 20947 | 0.110 |
Why?
|
Risk | 4 | 2021 | 9687 | 0.110 |
Why?
|
Adenosine A2 Receptor Agonists | 1 | 2012 | 27 | 0.110 |
Why?
|
Hypotension | 1 | 2018 | 884 | 0.110 |
Why?
|
Pyrazoles | 2 | 2013 | 1972 | 0.110 |
Why?
|
Frail Elderly | 1 | 2017 | 693 | 0.110 |
Why?
|
Reproducibility of Results | 10 | 2020 | 19905 | 0.100 |
Why?
|
Chi-Square Distribution | 2 | 2016 | 3508 | 0.100 |
Why?
|
Geriatric Assessment | 1 | 2019 | 1372 | 0.100 |
Why?
|
Body Weight | 1 | 2022 | 4669 | 0.100 |
Why?
|
Aortic Valve Stenosis | 1 | 2024 | 1965 | 0.100 |
Why?
|
Hyperglycemia | 1 | 2020 | 1373 | 0.100 |
Why?
|
Radiotherapy | 1 | 2018 | 1533 | 0.100 |
Why?
|
Overweight | 1 | 2022 | 2371 | 0.100 |
Why?
|
Heart Transplantation | 3 | 2019 | 3110 | 0.100 |
Why?
|
Body Mass Index | 3 | 2022 | 12720 | 0.100 |
Why?
|
Weight Loss | 1 | 2022 | 2622 | 0.100 |
Why?
|
Placebos | 3 | 2018 | 1676 | 0.090 |
Why?
|
Proteomics | 1 | 2024 | 3638 | 0.090 |
Why?
|
Heart-Assist Devices | 3 | 2017 | 1194 | 0.090 |
Why?
|
Adult | 21 | 2024 | 214055 | 0.090 |
Why?
|
Prevalence | 6 | 2020 | 15226 | 0.090 |
Why?
|
Diabetic Cardiomyopathies | 1 | 2011 | 96 | 0.090 |
Why?
|
Myocardial Ischemia | 2 | 2014 | 2148 | 0.090 |
Why?
|
Fasting | 1 | 2016 | 1593 | 0.090 |
Why?
|
alpha-Galactosidase | 1 | 2010 | 57 | 0.090 |
Why?
|
Coronary Aneurysm | 1 | 2012 | 237 | 0.090 |
Why?
|
Stress, Physiological | 2 | 2015 | 1403 | 0.090 |
Why?
|
Electrocardiography | 6 | 2016 | 6442 | 0.090 |
Why?
|
Hypertension, Pulmonary | 1 | 2020 | 1537 | 0.090 |
Why?
|
Fabry Disease | 1 | 2010 | 90 | 0.080 |
Why?
|
Death, Sudden, Cardiac | 4 | 2011 | 1541 | 0.080 |
Why?
|
Image Interpretation, Computer-Assisted | 3 | 2014 | 3327 | 0.080 |
Why?
|
Heart Diseases | 1 | 2022 | 2788 | 0.080 |
Why?
|
Retrospective Studies | 11 | 2023 | 77449 | 0.080 |
Why?
|
Myocarditis | 1 | 2016 | 771 | 0.080 |
Why?
|
Kidney | 3 | 2022 | 7186 | 0.080 |
Why?
|
Atrial Fibrillation | 2 | 2022 | 5034 | 0.080 |
Why?
|
Hypoglycemic Agents | 2 | 2023 | 2872 | 0.080 |
Why?
|
Pneumothorax | 1 | 2011 | 379 | 0.080 |
Why?
|
Cardiotonic Agents | 1 | 2011 | 535 | 0.080 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2008 | 188 | 0.070 |
Why?
|
Up-Regulation | 1 | 2016 | 4217 | 0.070 |
Why?
|
Patient Selection | 2 | 2016 | 4215 | 0.070 |
Why?
|
Recovery of Function | 2 | 2016 | 2925 | 0.070 |
Why?
|
Ultrasonography | 7 | 2011 | 5985 | 0.070 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2020 | 8949 | 0.070 |
Why?
|
Hemodynamics | 2 | 2014 | 4199 | 0.070 |
Why?
|
Exercise | 2 | 2024 | 5615 | 0.070 |
Why?
|
Acute Coronary Syndrome | 1 | 2020 | 2337 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 5 | 2019 | 35421 | 0.070 |
Why?
|
Echocardiography, Three-Dimensional | 1 | 2011 | 591 | 0.070 |
Why?
|
Thiazepines | 1 | 2005 | 30 | 0.070 |
Why?
|
Clinical Trials as Topic | 1 | 2001 | 7913 | 0.070 |
Why?
|
Comorbidity | 7 | 2019 | 10388 | 0.070 |
Why?
|
Image Enhancement | 1 | 2016 | 2921 | 0.060 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 2005 | 110 | 0.060 |
Why?
|
Decision Support Techniques | 1 | 2015 | 1956 | 0.060 |
Why?
|
Cardiovascular Agents | 1 | 2011 | 850 | 0.060 |
Why?
|
Risk Reduction Behavior | 1 | 2011 | 1125 | 0.060 |
Why?
|
Bundle-Branch Block | 1 | 2006 | 270 | 0.060 |
Why?
|
Pulmonary Ventilation | 2 | 2017 | 373 | 0.060 |
Why?
|
Linear Models | 1 | 2015 | 5952 | 0.060 |
Why?
|
Myocardium | 2 | 2014 | 4776 | 0.060 |
Why?
|
Creatine | 1 | 2006 | 421 | 0.060 |
Why?
|
Matrix Metalloproteinase 12 | 1 | 2024 | 49 | 0.060 |
Why?
|
Fluoroscopy | 1 | 2008 | 924 | 0.060 |
Why?
|
Ventricular Function | 1 | 2005 | 416 | 0.060 |
Why?
|
Glucocorticoids | 1 | 2013 | 2107 | 0.060 |
Why?
|
Endocarditis | 1 | 2008 | 350 | 0.060 |
Why?
|
Enalapril | 1 | 2005 | 327 | 0.060 |
Why?
|
Proteinuria | 1 | 2006 | 658 | 0.060 |
Why?
|
Heart Defects, Congenital | 1 | 2019 | 4584 | 0.050 |
Why?
|
Neprilysin | 1 | 2005 | 439 | 0.050 |
Why?
|
Sensitivity and Specificity | 5 | 2019 | 14722 | 0.050 |
Why?
|
Depression | 1 | 2021 | 7766 | 0.050 |
Why?
|
Research Design | 3 | 2013 | 5987 | 0.050 |
Why?
|
Cross-Sectional Studies | 3 | 2020 | 25043 | 0.050 |
Why?
|
Protease Inhibitors | 1 | 2005 | 791 | 0.050 |
Why?
|
Receptor, Angiotensin, Type 1 | 1 | 2001 | 152 | 0.050 |
Why?
|
Hydralazine | 1 | 2020 | 38 | 0.050 |
Why?
|
ROC Curve | 3 | 2014 | 3527 | 0.050 |
Why?
|
Diphosphates | 1 | 2020 | 88 | 0.050 |
Why?
|
Aftercare | 2 | 2022 | 866 | 0.050 |
Why?
|
Quality of Life | 1 | 2022 | 12804 | 0.050 |
Why?
|
Oxygen Consumption | 2 | 2017 | 1869 | 0.050 |
Why?
|
Renal Dialysis | 2 | 2020 | 1786 | 0.050 |
Why?
|
Surgery, Computer-Assisted | 1 | 2008 | 1018 | 0.040 |
Why?
|
Longitudinal Studies | 4 | 2021 | 13989 | 0.040 |
Why?
|
Postoperative Hemorrhage | 1 | 2023 | 413 | 0.040 |
Why?
|
Vital Capacity | 1 | 2022 | 925 | 0.040 |
Why?
|
Organ Size | 2 | 2020 | 2252 | 0.040 |
Why?
|
Echocardiography, Doppler, Color | 2 | 2013 | 364 | 0.040 |
Why?
|
Prealbumin | 1 | 2020 | 210 | 0.040 |
Why?
|
Logistic Models | 2 | 2011 | 13408 | 0.040 |
Why?
|
Gynecomastia | 1 | 2018 | 88 | 0.040 |
Why?
|
Hospitals | 2 | 2023 | 3952 | 0.040 |
Why?
|
Massachusetts | 3 | 2015 | 8663 | 0.040 |
Why?
|
Hypolipidemic Agents | 1 | 2002 | 604 | 0.040 |
Why?
|
Drug Combinations | 1 | 2022 | 1959 | 0.040 |
Why?
|
Kidney Diseases | 2 | 2006 | 2149 | 0.040 |
Why?
|
Renin-Angiotensin System | 1 | 2001 | 759 | 0.040 |
Why?
|
Mitral Valve Insufficiency | 1 | 2007 | 1422 | 0.040 |
Why?
|
Mortality | 2 | 2024 | 2864 | 0.040 |
Why?
|
Japan | 1 | 2020 | 1360 | 0.030 |
Why?
|
Feasibility Studies | 2 | 2018 | 5078 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2018 | 13695 | 0.030 |
Why?
|
Catheter Ablation | 1 | 2008 | 2758 | 0.030 |
Why?
|
Drug Therapy, Combination | 3 | 2015 | 6489 | 0.030 |
Why?
|
Potassium | 1 | 2018 | 1336 | 0.030 |
Why?
|
Morbidity | 2 | 2012 | 1769 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2021 | 20822 | 0.030 |
Why?
|
Thrombosis | 1 | 2008 | 2968 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2011 | 21746 | 0.030 |
Why?
|
Aldosterone | 1 | 2018 | 877 | 0.030 |
Why?
|
Radioisotopes | 1 | 2015 | 499 | 0.030 |
Why?
|
Technetium Tc 99m Sestamibi | 1 | 2014 | 177 | 0.030 |
Why?
|
Pyridines | 1 | 2005 | 2825 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2024 | 2585 | 0.030 |
Why?
|
Carbon Dioxide | 1 | 2017 | 1150 | 0.030 |
Why?
|
Kidney Function Tests | 1 | 2015 | 684 | 0.030 |
Why?
|
Pulmonary Embolism | 1 | 2005 | 2376 | 0.030 |
Why?
|
Cholesterol, LDL | 1 | 2021 | 2356 | 0.030 |
Why?
|
Recurrence | 3 | 2011 | 8340 | 0.030 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2013 | 314 | 0.030 |
Why?
|
Quality Control | 1 | 2015 | 841 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2014 | 15295 | 0.020 |
Why?
|
Lung | 2 | 2022 | 9856 | 0.020 |
Why?
|
Radiation Protection | 1 | 2015 | 419 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2004 | 3966 | 0.020 |
Why?
|
Internationality | 2 | 2007 | 1003 | 0.020 |
Why?
|
Chest Tubes | 1 | 2011 | 150 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2018 | 10943 | 0.020 |
Why?
|
Observer Variation | 2 | 2007 | 2593 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 2008 | 6364 | 0.020 |
Why?
|
Pancreatic Neoplasms | 1 | 2008 | 5256 | 0.020 |
Why?
|
Coronary Vessels | 1 | 2021 | 3107 | 0.020 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2004 | 3336 | 0.020 |
Why?
|
Patient Discharge | 1 | 2022 | 3313 | 0.020 |
Why?
|
Probability | 2 | 2005 | 2505 | 0.020 |
Why?
|
Multicenter Studies as Topic | 2 | 2004 | 1677 | 0.020 |
Why?
|
Perfusion | 1 | 2013 | 1360 | 0.020 |
Why?
|
Wounds, Penetrating | 1 | 2011 | 307 | 0.020 |
Why?
|
Ultrasonography, Doppler | 1 | 2011 | 458 | 0.020 |
Why?
|
Neoplasms | 1 | 2018 | 21683 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2019 | 6895 | 0.020 |
Why?
|
Chest Pain | 1 | 2016 | 1114 | 0.020 |
Why?
|
Vasodilator Agents | 1 | 2013 | 977 | 0.020 |
Why?
|
Calcium | 1 | 2021 | 5756 | 0.020 |
Why?
|
Thorax | 1 | 2011 | 547 | 0.020 |
Why?
|
Databases, Factual | 1 | 2023 | 7729 | 0.020 |
Why?
|
Carotid Artery Diseases | 1 | 2014 | 882 | 0.020 |
Why?
|
Pilot Projects | 1 | 2020 | 8324 | 0.020 |
Why?
|
Public Health | 1 | 2020 | 2603 | 0.020 |
Why?
|
Area Under Curve | 1 | 2011 | 1654 | 0.020 |
Why?
|
Survivors | 2 | 2008 | 2291 | 0.020 |
Why?
|
Lipids | 1 | 2018 | 3305 | 0.020 |
Why?
|
Boston | 1 | 2019 | 9313 | 0.020 |
Why?
|
Odds Ratio | 1 | 2019 | 9849 | 0.020 |
Why?
|
Cardiac Volume | 1 | 2007 | 210 | 0.020 |
Why?
|
Death, Sudden | 1 | 2008 | 302 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2012 | 2373 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2008 | 868 | 0.020 |
Why?
|
Chronic Disease | 2 | 2014 | 9146 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 2011 | 1265 | 0.020 |
Why?
|
Wounds, Nonpenetrating | 1 | 2011 | 794 | 0.020 |
Why?
|
Tachycardia, Ventricular | 1 | 2013 | 1273 | 0.020 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2011 | 964 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2013 | 1855 | 0.020 |
Why?
|
Contrast Media | 1 | 2018 | 5300 | 0.020 |
Why?
|
Biopsy | 1 | 2016 | 6756 | 0.020 |
Why?
|
Life Tables | 1 | 2004 | 370 | 0.020 |
Why?
|
Tricuspid Valve | 1 | 2007 | 403 | 0.010 |
Why?
|
Atrial Natriuretic Factor | 1 | 2005 | 393 | 0.010 |
Why?
|
Heart Function Tests | 1 | 2004 | 330 | 0.010 |
Why?
|
Tomography, Spiral Computed | 1 | 2005 | 280 | 0.010 |
Why?
|
Young Adult | 3 | 2019 | 56430 | 0.010 |
Why?
|
Pulmonary Veins | 1 | 2008 | 761 | 0.010 |
Why?
|
Adolescent | 3 | 2019 | 85781 | 0.010 |
Why?
|
Europe | 1 | 2008 | 3339 | 0.010 |
Why?
|
Sweden | 1 | 2004 | 1345 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2004 | 1590 | 0.010 |
Why?
|
Software | 1 | 2015 | 4443 | 0.010 |
Why?
|
Registries | 1 | 2015 | 8089 | 0.010 |
Why?
|
Canada | 1 | 2004 | 2065 | 0.010 |
Why?
|
Medical Records | 1 | 2004 | 1413 | 0.010 |
Why?
|
Reference Values | 1 | 2004 | 4982 | 0.010 |
Why?
|
Child, Preschool | 1 | 2019 | 41006 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2004 | 4933 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2004 | 6365 | 0.010 |
Why?
|
Acute Disease | 1 | 2005 | 7149 | 0.010 |
Why?
|
Inflammation | 1 | 2013 | 10638 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2008 | 12959 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2011 | 7659 | 0.010 |
Why?
|
Child | 1 | 2019 | 77709 | 0.010 |
Why?
|
Insulin | 1 | 2004 | 6580 | 0.010 |
Why?
|